Health2Tech

AMA president Dr. Jesse Ehrenfeld talks about medical debt, AI’s role in reducing burnout, value-based care, and global AI adoption differences. We also hear why he continues to see patients despite major leadership roles.

NYC Health + Hospitals Chief Quality Officer Dr. Komal Bajaj shares a candid view on hospital pilots, AI expectations, and startup red flags. We talk about quality, safety, and how founders can win (and keep) clinical partners.

HealthX Ventures principal Laura Hilty reflects on her journey from Epic operator to health tech investor. We discuss scalability challenges, what investors truly look for, and realistic roles for AI in care.

KeyCare CEO Dr. Lyle Berkowitz shares his “SAD” principle for fixing healthcare workflows: Simplify, Automate, and Delegate. We cover ambient AI, value-based care incentives, and why telehealth still underperforms its potential.

Cleveland Clinic’s Jennifer Owens opens up about driving AI programs inside a major health system. We talk decision-making in large organizations, GenAI use cases, model risks, and the future of US healthcare.

THYNK co-founder Jennifer Gentile explores game-based tools for brain function and mental health. We discuss telehealth’s early days, hardware integration, safety concerns, and funding strategies.

Carenostics COO Kanishka Rao explains how his company uses AI to detect chronic diseases earlier inside health systems. We cover grants, EHR integrations, incentives for prevention, and future expansion plans.

Rock Health’s Julia Croxen reviews the digital health market of 2024 and shares predictions for 2025. We talk investment trends, scaling challenges, Rock Health’s maturity curve, and what winning startups did differently.

Dr. Joseph Kvedar explains why home-based care and telehealth are central to the next phase of US healthcare. We cover business models, AI use cases, and what startups must nail to succeed in virtual care.

MindMics founder Dr. Anna Barnacka describes how she moved from astrophysics to in-ear cardiovascular monitoring. We talk about building novel sensors, high-fidelity data, and growing a deep-tech health startup.